Works matching IS 00099236 AND DT 2017 AND VI 102 AND IP 6

Results: 27

The Role of FcRn in the Pharmacokinetics of Biologics in Patients With Multiple Myeloma.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 903, doi. 10.1002/cpt.665
By:
- Jacobs, JFM;
- Mould, DR
Publication type:
Article
When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 924, doi. 10.1002/cpt.857
By:
- Franklin, Jessica M.;
- Schneeweiss, Sebastian
Publication type:
Article
Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 1006, doi. 10.1002/cpt.732
By:
- Checchio, T;
- Ahadieh, S;
- Gupta, P;
- Mandema, J;
- Puig, L;
- Wolk, R;
- Valdez, H;
- Tan, H;
- Krishnaswami, S;
- Tallman, A;
- Kaur, M;
- Ito, K
Publication type:
Article
Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 1017, doi. 10.1002/cpt.733
By:
- Plantinga, TS;
- Arts, P;
- Knarren, GH;
- Mulder, AH;
- Wakelkamp, IM;
- Hermus, AR;
- Joosten, LA;
- Netea, MG;
- Bisschop, PH;
- Herder, WW;
- Beijers, HJ;
- Bruin, IJ;
- Gilissen, C;
- Veltman, JA;
- Hoischen, A;
- Smit, JW;
- Netea‐Maier, RT
Publication type:
Article
Book Review: Introduction to Drug Disposition and Pharmacokinetics.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 893, doi. 10.1002/cpt.806
By:
- Beechinor, RJ;
- Gonzalez, D
Publication type:
Article
Issue Information.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 871, doi. 10.1002/cpt.498
Publication type:
Article
Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 951, doi. 10.1002/cpt.684
By:
- Gomeni, R;
- Bressolle‐Gomeni, FMM;
- Spencer, TJ;
- Faraone, SV;
- Fang, L;
- Babiskin, A
Publication type:
Article
Estimands: A More Strategic Approach to Study Design and Analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 894, doi. 10.1002/cpt.872
By:
- Akacha, Mouna;
- Kothny, Wolfgang
Publication type:
Article
Synergies From Integrating Randomized Controlled Trials and Real-World Data Analyses.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 914, doi. 10.1002/cpt.873
By:
- Najafzadeh, Mehdi;
- Gagne, Joshua J.;
- Schneeweiss, Sebastian
Publication type:
Article
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 897, doi. 10.1002/cpt.755
By:
- Relling, MV;
- Krauss, RM;
- Roden, DM;
- Klein, TE;
- Fowler, DM;
- Terada, N;
- Lin, L;
- Riel‐Mehan, M;
- Do, TP;
- Kubo, M;
- Yee, SW;
- Johnson, GT;
- Giacomini, KM
Publication type:
Article
PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 906, doi. 10.1002/cpt.756
By:
- Gutierrez‐Camino, A;
- Martin‐Guerrero, I;
- Garcia‐Orad, A
Publication type:
Article
Response to 'The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma'.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 905, doi. 10.1002/cpt.779
By:
- Xu, Xu Steven;
- Schecter, Jordan M.;
- Jansson, Richard;
- Yan, Xiaoyu
Publication type:
Article
Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 997, doi. 10.1002/cpt.720
By:
- Adiwijaya, BS;
- Kim, J;
- Lang, I;
- Csõszi, T;
- Cubillo, A;
- Chen, J‐S;
- Wong, M;
- Park, JO;
- Kim, JS;
- Rau, KM;
- Melichar, B;
- Gallego, JB;
- Fitzgerald, J;
- Belanger, B;
- Molnar, I;
- Ma, WW
Publication type:
Article
Impact of Digital Technologies on Novel Endpoint Capture in Clinical Trials.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 912, doi. 10.1002/cpt.866
By:
- Clay, Ieuan
Publication type:
Article
Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 908, doi. 10.1002/cpt.867
By:
- Lowe, Philip J.;
- Fink, Martin;
- Milton, Mark N.
Publication type:
Article
Innovation in the Design of Clinical Trials: Necessary for Innovation in Medicine.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 880, doi. 10.1002/cpt.868
By:
- Smith, Brian;
- Sander, Oliver
Publication type:
Article
Considerations for Evaluating Treatment Effects From Randomized Clinical Trials.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 917, doi. 10.1002/cpt.869
By:
- Ruberg, Stephen J.;
- Akacha, Mouna
Publication type:
Article
Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 934, doi. 10.1002/cpt.814
By:
- Simon, Richard
Publication type:
Article
ASCPT NEWS.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 885, doi. 10.1002/cpt.880
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 879, doi. 10.1002/cpt.881
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 883, doi. 10.1002/cpt.882
Publication type:
Article
Response to ' PNPLA3 rs738409 and Hepatotoxicity in Children With B-cell Acute Lymphoblastic Leukemia: A Validation Study in a Spanish Cohort'.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 907, doi. 10.1002/cpt.761
By:
- Liu, Y;
- Fernandez, CA;
- Relling, MV
Publication type:
Article
A New Paradigm. 'Learn - Learn More'; Dose-Exposure-Response at the Center of Drug Development and Regulatory Approval.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 942, doi. 10.1002/cpt.710
By:
- Maloney, Alan
Publication type:
Article
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 961, doi. 10.1002/cpt.711
By:
- Longo, DM;
- Generaux, GT;
- Howell, BA;
- Siler, SQ;
- Antoine, DJ;
- Button, D;
- Caggiano, A;
- Eisen, A;
- Iaci, J;
- Stanulis, R;
- Parry, T;
- Mosedale, M;
- Watkins, PB
Publication type:
Article
Moving Beyond Maximum Tolerated Dose for Targeted Oncology Drugs: Use of Clinical Utility Index to Optimize Venetoclax Dosage in Multiple Myeloma Patients.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 970, doi. 10.1002/cpt.712
By:
- Freise, KJ;
- Jones, AK;
- Verdugo, ME;
- Menon, RM;
- Maciag, PC;
- Salem, AH
Publication type:
Article
Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 977, doi. 10.1002/cpt.716
By:
- Abrantes, JA;
- Nielsen, EI;
- Korth‐Bradley, J;
- Harnisch, L;
- Jönsson, S
Publication type:
Article
Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 6, p. 989, doi. 10.1002/cpt.718
By:
- Vanhove, T;
- Bouillon, T;
- de Loor, H;
- Annaert, P;
- Kuypers, DRJ
Publication type:
Article